Sales decline 9.66% to Rs 384.33 crore
Net profit of Strides Pharma Science declined 70.89% to Rs 13.68 crore in the quarter ended September 2020 as against Rs 47.00 crore during the previous quarter ended September 2019. Sales declined 9.66% to Rs 384.33 crore in the quarter ended September 2020 as against Rs 425.41 crore during the previous quarter ended September 2019. ParticularsQuarter EndedSep. 2020Sep. 2019% Var.Sales384.33425.41 -10 OPM %5.0114.95 -PBDT43.3680.90 -46 PBT19.2058.21 -67 NP13.6847.00 -71Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
